Added to YB: 2024-10-31
Pitch date: 2024-10-29
VETO.PA [bullish]
Vetoquinol SA
-9.09%
current return
Author Info
DB_Silver_Fox is a CFO and value investor interested in: European & US hidden champions, simple and effective business models, and US Banks. Sign up for the newsletter.
Company Info
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
Market Cap
EUR 833.3M
Pitch Price
EUR 78.87
Price Target
N/A
Dividend
1.30%
EV/EBITDA
5.73
P/E
14.53
EV/Sales
1.19
Sector
Pharmaceuticals
Category
growth
$VETO.PA - Vetoquinol The French Animal healthcare company
VETO.PA: Family-owned (67%) French animal health co. Strong in pets/livestock niche, international focus (85% non-French sales). Conservative capital allocation, cash-rich, low debt. 11-13x EV/EBIT, 8.4% FCF yield. Growth drivers: Essentials & US market. Hidden champion characteristics. Potential undervaluation for high-quality business.
Read full article (2 min)